Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
Clinical trial NCT06468956 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06468956
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-14
- Primary completion
- 2026-03-31
- Enrollment
- 652
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.